← All themes

Genomics & Gene Editing

Genomics reads the genetic code and gene editing rewrites it, which can turn an inherited disease from a lifelong condition into a single treatment. Sequencing cost has fallen far enough to make study at population scale routine.

199 stocks

Gene Therapy

#	Name	Holding	Trade Value	Theme Stocks	% of Portfolio	Status
26	Bank of America Charlotte, North Carolina	$1.02B	+$1.02B	26	0.43%	New
27	BlackRock Group London, United Kingdom	$1B	+$985M	13	0.76%	New
28	Winslow Capital Management Minneapolis, Minnesota	$951M	+$926M	1	3.1%	New
29	Brown Brothers Harriman & Co New York	$924M	+$949M	6	4.38%	New
30	AllianceBernstein Nashville, Tennessee	$854M	+$813M	20	0.91%	New
31	Franklin Resources San Mateo, California	$840M	+$818M	8	0.48%	New
32	TIAA CREF Investment Management New York	$823M	+$800M	19	0.67%	New
33	BlackRock Advisors Wilmington, Delaware	$821M	+$804M	22	0.86%	New
34	UBS AM Chicago, Illinois	$821M	+$804M	15	1.06%	New
35	Geode Capital Management Boston, Massachusetts	$784M	+$774M	23	0.69%	New
36	Managed Account Advisors Jersey City, New Jersey	$765M	+$754M	14	1.18%	New
37	Ameriprise Minneapolis, Minnesota	$764M	+$752M	20	0.53%	New
38	Glenview Capital Management New York	$720M	+$708M	1	6.59%	New
39	Deutsche Bank Frankfurt Am Main Ge, Germany	$709M	+$700M	22	0.58%	New
40	Sands Capital Management Arlington, Virginia	$706M	+$731M	1	2.38%	New
41	Dimensional Fund Advisors Austin, Texas	$700M	+$700M	17	0.66%	New
42	Brown Advisory Baltimore, Maryland	$638M	+$626M	5	2.56%	New
43	ClearBridge Investments New York	$611M	+$576M	6	0.93%	New
44	1832 Asset Management Toronto, Ontario, Canada	$546M	+$543M	8	2.39%	New
45	Lord, Abbett & Co Jersey City, New Jersey	$533M	+$509M	9	1.24%	New
46	Credit Suisse Zurich, Switzerland	$502M	+$499M	22	0.51%	New
47	American Century Companies Kansas City, Missouri	$500M	+$503M	11	0.66%	New
48	Eagle Capital Management (New York) New York	$486M	+$478M	1	2.6%	New
49	Legal & General Group London, United Kingdom	$484M	+$476M	8	0.67%	New
50	PC Paulson & Co New York	$483M	+$475M	1	3.41%	New